Shibo Cong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shibo Cong has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Chai Xinlou
Beijing Univ Chinese Med Coll Chinese Med Beijing People's Republic of China
2 shared publicationsGu Shuxiao
Beijing Univ Chinese Med Coll Chinese Med Beijing People's Republic of China
2 shared publicationsLiu Susu
Beijing Univ Chinese Med Coll Chinese Med Beijing People's Republic of China
2 shared publicationsWang Sili
Beijing Univ Chinese Med Coll Chinese Med Beijing People's Republic of China
2 shared publications- Xinlou Chai
School of traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
2 shared publications Beijing University Of Chinese Medicine
1 shared publication
Latest Publications
- 16 January 2026
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 29
The Potential Mechanisms of Total Flavonoids of Drynaria roosii Nakaike in the Treatment of Ovariectomized Osteoporotic Rats through the SDF-1/CXCR4 Axis and BMSCs
Introduction: The aim of this study was to investigate the potential mechanisms and therapeutic effects of Total Flavonoids of Drynaria roosii Nakaike (TFRD) on osteoporotic rats following ovariectomy, through modulation of the stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor 4 (CXCR4) axis. Methods: Ovariectomized (OVX) osteoporotic rat models were established and treated with TFRD. The effects of TFRD on Bone Mineral Density (BMD), bone microarchitecture, and the expression of genes and proteins related to the SDF-1/CXCR4 axis in rat lumbar vertebrae were assessed using BMD measurement, bone histomorphology analysis, and molecular biology techniques. Results: In the TFRD treatment group, lumbar spine BMD significantly increased, and trabecular structure improved. Further mechanistic studies revealed that TFRD regulated SDF-1 expression, thereby promoting its binding to the CXCR4 receptor and, in turn, enhancing migration, homing, and osteogenic differentiation of BMSCs. These changes ultimately led to increased bone formation and decreased bone resorption, improving symptoms of osteoporosis. Discussion: This study provides novel insights into the molecular mechanism of TFRD gene therapy in OVX osteoporosis rats by elucidating its involvement through the SDF-1/CXCR4 axis and BMSCs-mediated osteogenic differentiation. Conclusion: These findings serve as a solid experimental and theoretical foundation for developing new anti-osteoporosis drugs. Furthermore, due to its natural plant extract origin, TFRD shows promising clinical application potential and requires further comprehensive investigation.
- 16 January 2026
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 29
The Potential Mechanisms of Total Flavonoids of Drynaria roosii Nakaike in the Treatment of Ovariectomized Osteoporotic Rats through the SDF-1/CXCR4 Axis and BMSCs
Introduction: The aim of this study was to investigate the potential mechanisms and therapeutic effects of Total Flavonoids of Drynaria roosii Nakaike (TFRD) on osteoporotic rats following ovariectomy, through modulation of the stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor 4 (CXCR4) axis. Methods: Ovariectomized (OVX) osteoporotic rat models were established and treated with TFRD. The effects of TFRD on Bone Mineral Density (BMD), bone microarchitecture, and the expression of genes and proteins related to the SDF-1/CXCR4 axis in rat lumbar vertebrae were assessed using BMD measurement, bone histomorphology analysis, and molecular biology techniques. Results: In the TFRD treatment group, lumbar spine BMD significantly increased, and trabecular structure improved. Further mechanistic studies revealed that TFRD regulated SDF-1 expression, thereby promoting its binding to the CXCR4 receptor and, in turn, enhancing migration, homing, and osteogenic differentiation of BMSCs. These changes ultimately led to increased bone formation and decreased bone resorption, improving symptoms of osteoporosis. Discussion: This study provides novel insights into the molecular mechanism of TFRD gene therapy in OVX osteoporosis rats by elucidating its involvement through the SDF-1/CXCR4 axis and BMSCs-mediated osteogenic differentiation. Conclusion: These findings serve as a solid experimental and theoretical foundation for developing new anti-osteoporosis drugs. Furthermore, due to its natural plant extract origin, TFRD shows promising clinical application potential and requires further comprehensive investigation.
- Open Access
- 12 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (8) , 3650
Mechanistic Integration of Network Pharmacology and In Vivo Validation: TFRD Combat Osteoporosis via PI3K/AKT Pathway Activation
In the context of osteoporosis closely linked to bone metabolism imbalance caused by estrogen deficiency, total flavonoids of Rhizoma Drynariae (TFRD) exhibit potential anti-osteoporotic activity, yet their multicomponent synergistic mechanism and association with the PI3K/AKT signaling pathway remain unclear. This study aimed to systematically elucidate the molecular mechanisms by which TFRD regulate bone metabolism and improve osteoporosis in ovariectomized (OVX) rats through the PI3K/AKT pathway, integrating network pharmacological predictions with animal experimental validation. Methods involved identifying TFRD’s active components using UPLC/MS-MS, predicting targets with SwissTargetPrediction, constructing a “component-target-disease” network, and performing GO/KEGG enrichment analysis with MetaScape (v3.5). In vivo experiments established an OVX rat model, randomized into sham, OVX, low-/high-dose TFRD, and sim groups, assessing bone mineral density (BMD) and mandibular Micro-CT parameters after 12 weeks. Western blot analyzed PI3K, p-AKT1, and related protein expressions. Results showed the high-dose TFRD group significantly increased BMD, improved trabecular bone quantity and structure, and upregulated PI3K, p-PI3K, and p-AKT1 protein expressions compared to the OVX group. Molecular docking confirmed stable binding energy between core components and PI3K/AKT targets. TFRD may ameliorate estrogen deficiency-induced osteoporosis by activating the PI3K/AKT signaling pathway, inhibiting bone resorption, and promoting osteogenic differentiation, providing pharmacological evidence for multitarget treatment of osteoporosis with traditional Chinese medicine.
- 12 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (8) , 3650
Open AccessMechanistic Integration of Network Pharmacology and In Vivo Validation: TFRD Combat Osteoporosis via PI3K/AKT Pathway Activation
In the context of osteoporosis closely linked to bone metabolism imbalance caused by estrogen deficiency, total flavonoids of Rhizoma Drynariae (TFRD) exhibit potential anti-osteoporotic activity, yet their multicomponent synergistic mechanism and association with the PI3K/AKT signaling pathway remain unclear. This study aimed to systematically elucidate the molecular mechanisms by which TFRD regulate bone metabolism and improve osteoporosis in ovariectomized (OVX) rats through the PI3K/AKT pathway, integrating network pharmacological predictions with animal experimental validation. Methods involved identifying TFRD’s active components using UPLC/MS-MS, predicting targets with SwissTargetPrediction, constructing a “component-target-disease” network, and performing GO/KEGG enrichment analysis with MetaScape (v3.5). In vivo experiments established an OVX rat model, randomized into sham, OVX, low-/high-dose TFRD, and sim groups, assessing bone mineral density (BMD) and mandibular Micro-CT parameters after 12 weeks. Western blot analyzed PI3K, p-AKT1, and related protein expressions. Results showed the high-dose TFRD group significantly increased BMD, improved trabecular bone quantity and structure, and upregulated PI3K, p-PI3K, and p-AKT1 protein expressions compared to the OVX group. Molecular docking confirmed stable binding energy between core components and PI3K/AKT targets. TFRD may ameliorate estrogen deficiency-induced osteoporosis by activating the PI3K/AKT signaling pathway, inhibiting bone resorption, and promoting osteogenic differentiation, providing pharmacological evidence for multitarget treatment of osteoporosis with traditional Chinese medicine.
- 11 January 2024
- Published by Wiley in Peptide Science
- Vol. 116 (3)
Molecular mechanism study and potential active ingredients prediction of Danhe granules in the treatment of hypercholesterolemia via TICE
This study aims to explore the molecular mechanism and potential active ingredients of Danhe granules in improving the blood lipid level of hypercholesterolemia by intestinal TICE (transintestinal cholesterol excretion) through in vivo experimental research, network pharmacology methods, and molecular docking. The diet‐induced hypercholesterolemia rat model evaluated the effects of Danhe granules on fecal cholesterol levels and intestinal TICE‐related protein expression in rats. Based on the experimental results, the network pharmacology method was used to predict the potential active ingredients, and the binding strength between the potential active ingredients and key targets was further confirmed by molecular docking. Danhe granules increased LDLR, ABCG5, ABCB1, and LXRα which can promote the uptake of cholesterol by intestinal cells and the excretion of cholesterol into the intestine, and then reduce the levels of serum LDL‐C and TC and increase the level of fecal TC, so as to achieve the effect of treating hypercholesterolemia. The results of network pharmacology and molecular docking showed that 19 active ingredients had good binding activity with the targets. These may be the active ingredients of Danhe granules for the treatment of hypercholesterolemia. This study revealed the molecular mechanism of Danhe granules in the treatment of hypercholesterolemia via TICE, and preliminarily clarified the potential effective ingredients. It provides new ideas for the treatment of hypercholesterolemia and the development of new drugs.
- 11 January 2024
- Published by Wiley in Peptide Science
- Vol. 116 (3)
Molecular mechanism study and potential active ingredients prediction of Danhe granules in the treatment of hypercholesterolemia via TICE
This study aims to explore the molecular mechanism and potential active ingredients of Danhe granules in improving the blood lipid level of hypercholesterolemia by intestinal TICE (transintestinal cholesterol excretion) through in vivo experimental research, network pharmacology methods, and molecular docking. The diet‐induced hypercholesterolemia rat model evaluated the effects of Danhe granules on fecal cholesterol levels and intestinal TICE‐related protein expression in rats. Based on the experimental results, the network pharmacology method was used to predict the potential active ingredients, and the binding strength between the potential active ingredients and key targets was further confirmed by molecular docking. Danhe granules increased LDLR, ABCG5, ABCB1, and LXRα which can promote the uptake of cholesterol by intestinal cells and the excretion of cholesterol into the intestine, and then reduce the levels of serum LDL‐C and TC and increase the level of fecal TC, so as to achieve the effect of treating hypercholesterolemia. The results of network pharmacology and molecular docking showed that 19 active ingredients had good binding activity with the targets. These may be the active ingredients of Danhe granules for the treatment of hypercholesterolemia. This study revealed the molecular mechanism of Danhe granules in the treatment of hypercholesterolemia via TICE, and preliminarily clarified the potential effective ingredients. It provides new ideas for the treatment of hypercholesterolemia and the development of new drugs.
- Open Access
- 21 December 2023
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 14, 1278952
Frontiers and hotspots of adipose tissue and NAFLD: a bibliometric analysis from 2002 to 2022
Background: The annual incidence of non-alcoholic fatty liver disease (NAFLD) continues to rise steadily. In recent years, adipose tissue (AT) has gained recognition as a pivotal contributor to the pathogenesis of NAFLD. Employing bibliometric analysis, we examined literature concerning AT and NAFLD.Methods: Relevant literature on AT in NAFLD from 1980 to 2022 was extracted from the Web of Science Core Collection. These records were visualized using CiteSpace and VOSviewer regarding publications, countries/regions, institutions, authors, journals, references, and keywords.Results: Since 2002, a total of 3,330 papers have been included, exhibiting an annual surge in publications. Notably, the quality of publications is superior in the USA and Europe. Kenneth Cusi stands out as the author with the highest number of publications and H-index. Hepatology is the journal boasting the highest citation and H-index. The University of California System holds the highest centrality among institutions. References specifically delve into physiological processes associated with AT in NAFLD. Currently, lipid metabolism and inflammation constitute the principal research mechanisms in the AT-based regulation of NAFLD, with pertinent keywords including microRNA, T cell, hypoxia, sarcopenia, hepatokine, gut microbiota, and autophagy. The Mediterranean diet is among the most widely recommended dietary approaches for potential NAFLD treatment.Conclusion: This paper represents the inaugural bibliometric study on the effects of AT on NAFLD, offering valuable insights and directions for future research.
- 21 December 2023
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 14, 1278952
Open AccessFrontiers and hotspots of adipose tissue and NAFLD: a bibliometric analysis from 2002 to 2022
Background: The annual incidence of non-alcoholic fatty liver disease (NAFLD) continues to rise steadily. In recent years, adipose tissue (AT) has gained recognition as a pivotal contributor to the pathogenesis of NAFLD. Employing bibliometric analysis, we examined literature concerning AT and NAFLD.Methods: Relevant literature on AT in NAFLD from 1980 to 2022 was extracted from the Web of Science Core Collection. These records were visualized using CiteSpace and VOSviewer regarding publications, countries/regions, institutions, authors, journals, references, and keywords.Results: Since 2002, a total of 3,330 papers have been included, exhibiting an annual surge in publications. Notably, the quality of publications is superior in the USA and Europe. Kenneth Cusi stands out as the author with the highest number of publications and H-index. Hepatology is the journal boasting the highest citation and H-index. The University of California System holds the highest centrality among institutions. References specifically delve into physiological processes associated with AT in NAFLD. Currently, lipid metabolism and inflammation constitute the principal research mechanisms in the AT-based regulation of NAFLD, with pertinent keywords including microRNA, T cell, hypoxia, sarcopenia, hepatokine, gut microbiota, and autophagy. The Mediterranean diet is among the most widely recommended dietary approaches for potential NAFLD treatment.Conclusion: This paper represents the inaugural bibliometric study on the effects of AT on NAFLD, offering valuable insights and directions for future research.
- Open Access
- 8 November 2023
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 7 (1) , e460
Emerging trends and hotspots in the links between the bile acids and NAFLD from 2002 to 2022: A bibliometric analysis
Background: Non‐alcoholic fatty liver disease (NAFLD) is a metabolic syndrome of the liver, and its incidence is increasing worldwide. Accumulating evidence suggests that bile acids are associated with NAFLD. Although many studies on bile acids and NAFLD have been published over the past 20 years, the authors of this study have not found a relevant bibliometric analysis in this field. Therefore, this study aimed to evaluate the trend of publications, summarize current research hotspots and predict future research directions through bibliometric analysis in this field.Method: Articles related to bile acids and NAFLD published between 2002 and 2022 were obtained from the Science Citation Index‐Expanded of Web of Science Core Collection. Microsoft Excel, CiteSpace, VOSviewer and Bibliometric Online Analysis Platform were used to analyse the publication trends and research hotspots in this field.Results: Among the articles published between 2002 and 2022, we retrieved 1284 articles related to bile acids and NAFLD, and finally included 568 articles. The USA was dominant until 2020, after which China surpassed the USA to become the dominant force. These two countries cooperate the most closely, and are also the most active in international cooperation. The University of California (UCL) was the most published institution, with a total of 31 publications. There were six authors who have published nine articles and ranked first. The keywords cluster labels show the 10 main clusters: #0fatty liver, #1obeticholic acid, #2oxidative stress, #37 alpha hydroxy 4 cholesten 3 one, #4deoxycholic acid, #5nonalcoholic fatty liver disease, #6mouse model, #7fibroblast growth factor 21, #8animal models, #9high‐fat diet. Keywords burst analysis revealed a higher intensity of study for the nuclear receptor, FXR, and metabolic syndrome.Conclusion: Bile acids have become an important research direction in the field of NAFLD, and the intervention of gut microbiota in NAFLD by acting on bile acids may become a potential hotspot for future research. This study provides reference and guidance for future research, and will help scholars better explore the field and innovatively discover the mechanisms and treatments of NAFLD.
- 8 November 2023
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 7 (1) , e460
Open AccessEmerging trends and hotspots in the links between the bile acids and NAFLD from 2002 to 2022: A bibliometric analysis
Background: Non‐alcoholic fatty liver disease (NAFLD) is a metabolic syndrome of the liver, and its incidence is increasing worldwide. Accumulating evidence suggests that bile acids are associated with NAFLD. Although many studies on bile acids and NAFLD have been published over the past 20 years, the authors of this study have not found a relevant bibliometric analysis in this field. Therefore, this study aimed to evaluate the trend of publications, summarize current research hotspots and predict future research directions through bibliometric analysis in this field.Method: Articles related to bile acids and NAFLD published between 2002 and 2022 were obtained from the Science Citation Index‐Expanded of Web of Science Core Collection. Microsoft Excel, CiteSpace, VOSviewer and Bibliometric Online Analysis Platform were used to analyse the publication trends and research hotspots in this field.Results: Among the articles published between 2002 and 2022, we retrieved 1284 articles related to bile acids and NAFLD, and finally included 568 articles. The USA was dominant until 2020, after which China surpassed the USA to become the dominant force. These two countries cooperate the most closely, and are also the most active in international cooperation. The University of California (UCL) was the most published institution, with a total of 31 publications. There were six authors who have published nine articles and ranked first. The keywords cluster labels show the 10 main clusters: #0fatty liver, #1obeticholic acid, #2oxidative stress, #37 alpha hydroxy 4 cholesten 3 one, #4deoxycholic acid, #5nonalcoholic fatty liver disease, #6mouse model, #7fibroblast growth factor 21, #8animal models, #9high‐fat diet. Keywords burst analysis revealed a higher intensity of study for the nuclear receptor, FXR, and metabolic syndrome.Conclusion: Bile acids have become an important research direction in the field of NAFLD, and the intervention of gut microbiota in NAFLD by acting on bile acids may become a potential hotspot for future research. This study provides reference and guidance for future research, and will help scholars better explore the field and innovatively discover the mechanisms and treatments of NAFLD.
- Open Access
- 25 September 2023
- Published by Elsevier in Journal of Traditional Chinese Medical Sciences
- Vol. 10 (4) , 415-426
Systematic review of randomized controlled trials on Gong Liu Ning as a complimentary therapy in the treatment of uterine fibroids
- 25 September 2023
- Published by Elsevier in Journal of Traditional Chinese Medical Sciences
- Vol. 10 (4) , 415-426
Open AccessSystematic review of randomized controlled trials on Gong Liu Ning as a complimentary therapy in the treatment of uterine fibroids
- Open Access
- 26 April 2023
- Published by Herald Scholarly Open Access in Journal of Alternative, Complementary & Integrative Medicine
- Vol. 9 (3) , 1-13
Explore the Mechanism of LiYin Decoction in Treating Nonalcoholic Steatohepatitis and Atherosclerosis with Homotherapy for Heteropathy Based on Network Pharmacology and Molecular Docking
This study preliminarily revealed the potential mechanism of multiple ingredients in LYD to treat NASH and AS with homotherapy for heteropathy through multiple targets and ways, provided theoretical basis for further research on the mechanism of action and clinical application of LYD.
- 26 April 2023
- Published by Herald Scholarly Open Access in Journal of Alternative, Complementary & Integrative Medicine
- Vol. 9 (3) , 1-13
Open AccessExplore the Mechanism of LiYin Decoction in Treating Nonalcoholic Steatohepatitis and Atherosclerosis with Homotherapy for Heteropathy Based on Network Pharmacology and Molecular Docking
This study preliminarily revealed the potential mechanism of multiple ingredients in LYD to treat NASH and AS with homotherapy for heteropathy through multiple targets and ways, provided theoretical basis for further research on the mechanism of action and clinical application of LYD.